Cheng-Ai Wu

Cheng-Ai Wu


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2016 in Orthopaedic Surgery
Verified
Journal Article
Open access
PDF file
XJXu Jiang
Xu Jiang
QWQian‐Qian Wang
Qian‐Qian Wang
CWCheng-Ai Wu
Cheng-Ai Wu
WTWei Tian
Wei Tian
The aim of this meta‐analysis and systematic review of randomized controlled trials (RCTs) was to evaluate the efficacy and safety of adductor canal block (ACB) for early postoperative pain management in patients undergoing total knee arthroplasty (TKA). Relevant manuscripts comparing ACB with saline or femoral nerve block (FNB) in TKA patients were searched for in the databases of PubMed, EMBASE, and Cochrane library. The outcomes assessed included cumulative analgesic consumption, pain at rest or during movement, ability to ambulate, quadriceps strength, and complications (nausea, vomiting or sedation). For continuous outcomes, pooled effects were measured using weighted mean difference (WMD) or standard mean difference (SMD), together with 95% confidence intervals (CIs). For outcomes without sufficient data for synthesis, qualitative interpretation of individual studies was summarized. Finally, 11 RCTs involving 675 patients met the inclusion criteria. The pooled results showed that ACB resulted in less postoperative analgesic consumption than saline (WMD, −12.84 mg; 95% CI, −19.40 mg to −6.27 mg; P < 0.001) and less pain at rest or during activity. No conclusions could be drawn regarding ability to ambulate and quadriceps strength, because only one study reported these variables. Most studies comparing ACB and FNB reported similar effects on postoperative analgesic consumption (WMD, −0.56 mg; 95% CI, −8.05 mg to 6.93 mg; P = 0.884) and pain; however, ability to ambulate and quadriceps strength were significantly better with ACB (SMD, 0.99; 95% CI, 0.04–1.94; P = 0.041). Additionally, ACB did not increase the rate of complications. Our results suggest that, compared with saline, ACB decreases analgesic consumption and offers short‐term advantages in terms of pain relief. Compared with FNB, ACB was associated with better ability to ambulate and quadriceps strength.

1 March 2021 in Annals of Translational Medicine
Verified
Journal Article
Open access
PDF file
ZWZhen-Jie Wei
Zhen-Jie Wei
QWQian-Qian Wang
Qian-Qian Wang
ZCZheng-Guo Cui
Zheng-Guo Cui
HIHidekuni Inadera
Hidekuni Inadera
XJXu Jiang
Xu Jiang
CWCheng-Ai Wu
Cheng-Ai Wu
Background: Due to varying degrees of difficulty in obtaining different mesenchymal stem cells (MSCs), the distinct pain levels and treatment costs, and for providing concrete evidence for future clinical practice, a thorough comparison of all relevant MSCs remained critical. Hence, this study aimed to achieve this objective to compare the efficacy of MSCs obtained from different sources in clinical outcomes and cartilage repair of knee osteoarthritis (KOA). Methods: The EmBase, PubMed and Cochrane Library databases were searched for eligible studies. Randomized controlled trials (RCTs) that compared MSCs from different sources with placebo or each other in KOA patients. Conventional meta-analysis and frequentist network meta-analysis (NMA) were conducted. The primary clinical outcome was pain relief. The frequentist NMA was conducted using Stata with the “network” command. Results: Eight studies (seven trials) involving 203 KOA patients were included in this meta-analysis. The MSCs were considered superior over placebo for pain relief and improved function in KOA, but showed no statistically significant differences for cartilage regeneration. Among all the MSCs, the adipose tissue-derived MSCs (AD-MSCs) most effectively relieved pain. Conclusion: These findings suggested that MSCs are effective in the treating of KOA. AD-MSCs might be the most effective for relieving pain, and Umbilical cord-derived mesenchymal stem cells (UC-MSCs) might be the most effective for improving function. However, the current evidence does not support the use of MSCs for improving cartilage repair in KOA patients.

12 February 2021 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
XSXiong Shu
Xiong Shu
KCKai-Yue Cao
Kai-Yue Cao
HLHui-Qi Liu
Hui-Qi Liu
LYLong Yu
Long Yu
LSLi-Xin Sun
Li-Xin Sun
YRYu-Liang Ran
Yu-Liang Ran
Background: Tumor-associated antigens (TAAs) can be targeted in cancer therapy. We previously identified a monoclonal antibody (mAb) 12C7, which presented anti-tumor activity in lung cancer stem cells (LCSCs). Here, we aimed to identify the target antigen for 12C7 and confirm its role in LCSCs. Methods: Immunofluorescence was used for antigen localization. After targeted antigen purification by electrophoresis and immunoblot, the antigen was identified by LC-MALDI-TOF/TOF mass spectrometry, immunofluorescence, and immunoprecipitation. The overexpression or silence of ENO1 was induced by lentiviral transduction. Self-renewal, growth, and invasion of LCSCs were evaluated by sphere formation, colony formation, and invasion assay, respectively. High-throughput transcriptome sequencing (RNA-seq) and bioinformatics analysis were performed to analyze downstream targets and pathways of targeted antigen. Results: Targeted antigen showed a surface antigen expression pattern, and the 43–55 kDa protein band was identified as α-enolase (ENO1). Self-renewal, growth, and invasion abilities of LCSCs were remarkably inhibited by ENO1 downregulation, while enhanced by ENO1 upregulation. RNA-seq and bioinformatics analysis eventually screened 4 self-renewal-related and 6 invasion-related differentially expressed genes. GSEA analysis and qRT-PCR verified that ENO1 regulated self-renewal, invasion-related genes, and pathways. KEGG pathway analysis and immunoblot demonstrated that ENO1 inactivated AMPK pathway and activated mTOR pathway in LCSCs. Conclusions: ENO1 is identified as a targeted antigen of mAb 12C7 and plays a pivotal role in facilitating self-renewal, growth, and invasion of LCSCs. These findings provide a potent therapeutic target for the stem cell therapy for lung cancer and have potential to improve the anti-tumor activity of 12C7.

15 February 2022 in BMC Public Health
Verified
Journal Article
Open access
PDF file
QWQianqian Wang
Qianqian Wang
YZYanzhuo Zhang
Yanzhuo Zhang
CWCheng-Ai Wu
Cheng-Ai Wu
Background: This study aimed to investigate alcohol consumption and associated factors in middle-aged and older adults. Materials and methods: We included 15,942 participants (7,384 men, 8558 women) with age range of 45-101 years from the 2011 baseline survey of the China Health and Retirement Longitudinal Study. Variables related to alcohol status and other potential risk factors were selected for analysis. Logistic regression analysis was used to analyze the factors associated with drinking. Results: There was a significantly higher proportion of current drinkers among men than women (36.42% ± 0.86% vs. 3.73% ± 0.27%). Among the current drinkers, proportions of binge drinking, heavy drinking and daily drinking were 38.2, 53.0, 57.5% for men and 10.9, 37.2, 36.2% for women, respectively. Factors significantly associated with current drinking were age, health situation, smoking, geographic region, work status and social activities among men, and age, smoking, geographic region and work status among women. The favorite type of alcohol was spirits for both men and women. The type of beverage intake was also related socio- cultural-demographic factors as mentioned above. Conclusions: Alcohol consumption behaviors and type of beverage was significantly influenced by socio- cultural-demographic factors. The socio-cultural-demographic factors affecting alcohol patterns should be further focused on to promote the development of alcohol control strategies.

21 December 2020 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
RSrui Shi
rui Shi
JZJingshuang Zhang
Jingshuang Zhang
KNKun Niu
Kun Niu
WLWeiyang Li
Weiyang Li
NJNi Jiang
Ni Jiang
CWCheng-Ai Wu
Cheng-Ai Wu
We fabricate a nanofiber membrane encapsulated with DFO-loaded nanoparticles (NPs) and free DFO. Through the osteogenic properties, we speculate that DFO in the nanofiber membranes contributes to osteogenesis through the TGF-β1/Smad2 signaling pathway.

17 November 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SYShunan Yu
Shunan Yu
XSXiong Shu
Xiong Shu
LCLei Chen
Lei Chen
CWChao Wang
Chao Wang
XWXinyu Wang
Xinyu Wang
CWCheng-Ai Wu
Cheng-Ai Wu
A novel tissue-specific functional tissue engineering scaffold for cartilage repair should have a three-dimensional structure, good biosafety and biological activity, and should be able to promote cartilage tissue regeneration. This study aimed to determine the effect of ultrasound-treated collagen/silk fibroin (Col/SF) composite scaffolds with good mechanical properties and high biological activity on cartilage repair. The characteristics of the scaffolds with different Col/SF ratios (7:3, 8:2, and 9:1) were determined by scanning electron microscopy, Fourier-transform infrared spectroscopy, and porosity, water absorption, and compression tests. In vitro evaluations revealed the biocompatibility of the Col/SF scaffolds. Results suggested that the optimal ratio of Col/SF composite scaffolds was 7:3. The Col/SF scaffolds induced adipose-derived stem cells to undergo chondrogenic differentiation under chondrogenic culture conditions. The efficiency of Col/SF scaffolds for cartilage regeneration applications was further evaluated using an in vivo model of full-thickness articular cartilage defects in New Zealand rabbits. The Col/SF scaffolds effectively promoted osteochondral regeneration as evidenced by macroscopic, histological, and immunohistochemical evaluation. The study demonstrates that ultrasound-treated Col/SF scaffolds show great potential for repairing cartilage defects.